FeesSafety
Pluang+

Morpho's real-world-asset lending hits $2.145B deposits and $894M loans, showing strong growth in tokenized asset markets.

Protocol Fundamentals
29 Oct 2026, 03:22 WIB
Tokenpost
View Source
Bullish
Morpho's real-world-asset lending hits $2.145B deposits and $894M loans, showing strong growth in tokenized asset markets.

Morpho's real-world-asset (RWA) markets reported $2.145 billion in deposits and $894.18 million in outstanding loans as of October 28, marking significant growth from earlier months. Deposits increased by 48.7% and loans by 55.8% since July 1, reflecting rising activity in lending tied to tokenized assets. The collateral backing these loans totaled $1.10 billion, concentrated in a few key assets like PRIME and PT-reUSD. Risks remain from market liquidity issues and potential loan liquidations if loan-to-value ratios exceed thresholds, but the data highlights expanding use of tokenized assets in private credit markets.

Morpho's real-world-asset (RWA) markets show $2.14 billion in deposits and $894 million in outstanding loans as of late October, providing context on tokenized asset lending growth. For readers following cryptocurrency markets on Pluang, as of Oct 29, 2026 07:02 WIB, 42 of 50 major cryptocurrencies rose and 7 fell. Notable movers include BAL at Rp16.297 (+11.14%), EOS at Rp12.649 (+8.13%), and CAKE at Rp38.831 (+5.02%) with a 43% sell / 57% buy order split and typical hold time of 75 days.

More News

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market to reach $8.04B by 2032, driven by cafe culture and specialty coffee growth.

China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...

Market News
Neutral
1 hour ago
FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

FDA grants orphan drug status to sovleplenib for rare autoimmune disease ITP treatment

HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...

Market News
Bullish
1 hour ago
LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED hosts global media test drive showcasing advanced tech and luxury in new LLounge and Stormax models.

LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...

Market News
Bullish
1 hour ago
Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Law firm investigates NVE Corporation over sharp Q2 revenue drop and stock plunge.

Kirby McInerney LLP is investigating NVE Corporation for possible violations of federal securities laws after the company reported a 47% revenue decline and a 33.7% stock price drop following its Q2 fiscal 2027 results. The revenue fall was attribute...

Market News
Bearish
3 hours ago
Bitcoin whales show mixed moves amid macro events, hinting at a potential breakout above $80k.

Bitcoin whales show mixed moves amid macro events, hinting at a potential breakout above $80k.

Bitcoin whales are sending mixed signals with some moving $200 million worth of BTC to exchanges, indicating possible selling pressure, while others accumulate large amounts off exchanges. This activity occurs amid a volatile macroeconomic environmen...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App